Your doctor should assess several factors before approving discontinuation, including your current weight status and trajectory, the presence and control of obesity-related comorbidities (type 2 diabetes, hypertension, sleep apnea, cardiovascular disease), your readiness and capacity to implement intensive lifestyle modifications, available support systems and resources, and your history of weight cycling or previous weight loss attempts
However, there was no significant difference in adverse CVEs or all-cause mortality when compared with those taking SGLT2 inhibitors
A: These supplements are manufactured in India in a GMP certified facility
Studies show that 40 to 85 percent of people taking standard doses of GLP-1s have side effects, most often gastrointestinal troubles like nausea and vomiting
Localized injections (e.g., into the biceps, quads, or delts) may enhance regional growth, though systemic effects will still occur